| Influenza A virus replicates productively in primary human kidney cells and induces factors and mechanisms related to regulated cell death and renal pathology observed in virus … B Koch, M Shehata, C Müller-Ruttloff, SA Gouda, N Wetzstein, S Patyna, ... Frontiers in Cellular and Infection Microbiology 14, 1363407, 2024 | | 2024 |
| Evaluation of Predicted siRNA as an Antiviral against MERS-CoV Targeting the Membrane Gene in the Vero Cell Line AY El-Sayed, M Shehata, SH Mahmoud, M ElHefnawi, DM Seoudi, MA Ali Microbiology Research 14 (4), 1687-1701, 2023 | | 2023 |
| NRF2 activators inhibit influenza A virus replication by interfering with nucleo-cytoplasmic export of viral RNPs in an NRF2-independent manner FH Waqas, M Shehata, WAM Elgaher, A Lacour, N Kurmasheva, ... PLoS Pathogens 19 (7), e1011506, 2023 | 10 | 2023 |
| In Silico and In Vitro Development of novel small interfering RNAs (siRNAs) to inhibit SARS-CoV-2 NS Taibe, SH Mahmoud, MA Kord, MA Badawy, M Shehata, M Elhefnawi | | 2023 |
| Phosphorylation of influenza a virus matrix protein 1 at threonine 108 controls its multimerization state and functional association with the STRIPAK complex L Liu, A Weber, U Linne, M Shehata, S Pleschka, M Kracht, ML Schmitz MBio 14 (1), e03231-22, 2023 | 3 | 2023 |
| Correction: Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection A Sohail, AA Iqbal, N Sahini, F Chen, M Tantawy, SFH Waqas, ... Plos Pathogens 18 (11), e1011002, 2022 | 2 | 2022 |
| Immunogenicity and effectiveness of a bivalent influenza A/H1N2 vaccine strain against seasonal human influenza A viruses in mice MN Kamel, SH Mahmoud, Y Moatasim, A El Taweel, M Shehata, ... Journal of Genetic Engineering and Biotechnology 20 (1), 155, 2022 | 2 | 2022 |
| Robust Antiviral Activity of Santonica Flower Extract (Artemisia cina) against Avian and Human Influenza A Viruses: In Vitro and Chemoinformatic Studies A Hegazy, I Mostafa, YAMM Elshaier, SH Mahmoud, NM Abo Shama, ... ACS omega 7 (45), 41212-41223, 2022 | 14 | 2022 |
| Broad Antiviral Effects of Echinacea purpurea against SARS-CoV-2 Variants of Concern and Potential Mechanism of Action S Vimalanathan, M Shehata, K Sadasivam, S Delbue, M Dolci, E Pariani, ... Microorganisms 10 (11), 2145, 2022 | 11 | 2022 |
| Possible correlation between probiotic activity of bacterial honey isolates and severe acute respiratory syndrome coronavirus 2 replication in vitro A Ezzat, NO Abdelsamad, AA Gamal, M Shehata, SH Mahmoud, ... Egyptian Journal of Chemistry 65 (9), 467-476, 2022 | | 2022 |
| Strong anti-SARS-CoV-2 activity of Lucilia cuprina maggots’ excretion/secretion and its effect on viral entry and notch pathway in vitro: First work MRK Abdel-Samad, FA Taher, M Shehata, NMA Shama, A Mostafa, ... Journal of Applied Pharmaceutical Science 12 (7), 122-130, 2022 | | 2022 |
| Citraconate inhibits ACOD1 (IRG1) catalysis, reduces interferon responses and oxidative stress, and modulates inflammation and cell metabolism F Chen, WAM Elgaher, M Winterhoff, K Büssow, FH Waqas, E Graner, ... Nature Metabolism 4 (5), 534-546, 2022 | 65 | 2022 |
| Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection A Sohail, AA Iqbal, N Sahini, F Chen, M Tantawy, SFH Waqas, ... PLoS pathogens 18 (1), e1010219, 2022 | 53 | 2022 |
| Possible correlation between the probiotic activity of bacterial honey isolates and the in vitro inhibition of coronavirus 2 replication responsible for acute respiratory syndromes A Ezzat, NO Abdelsamad, AA Gamal, M Shehata, SH Mahmoud, ... Egyptian Journal of Chemistry 65 (9), 467-476, 2022 | 1 | 2022 |
| Discovery of novel oxazole-based macrocycles as anti-coronaviral agents targeting SARS-CoV-2 main protease LH Al-Wahaibi, A Mostafa, YA Mostafa, OF Abou-Ghadir, AH Abdelazeem, ... Bioorganic Chemistry 116, 105363, 2021 | 12 | 2021 |
| Naturally available flavonoid aglycones as potential antiviral drug candidates against SARS-CoV-2 AA Al-Karmalawy, MM Farid, A Mostafa, AY Ragheb, S H. Mahmoud, ... Molecules 26 (21), 6559, 2021 | 65 | 2021 |
| In silico and in vivo evaluation of SARS-CoV-2 predicted epitopes-based candidate vaccine MM Shehata, SH Mahmoud, M Tarek, AA Al-Karmalawy, A Mahmoud, ... Molecules 26 (20), 6182, 2021 | 24 | 2021 |
| Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies A Mahmoud, A Mostafa, AA Al-Karmalawy, A Zidan, HS Abulkhair, ... Heliyon 7 (9), 2021 | 72 | 2021 |
| Strong inhibitory activity and action modes of synthetic maslinic acid derivative on highly pathogenic coronaviruses: COVID-19 drug candidate R Soltane, A Chrouda, A Mostafa, AA Al-Karmalawy, K Chouaïb, A Dhahri, ... Pathogens 10 (5), 623, 2021 | 48 | 2021 |
| Incidence, household transmission, and neutralizing antibody seroprevalence of Coronavirus Disease 2019 in Egypt: Results of a community-based cohort MR Gomaa, AS El Rifay, M Shehata, A Kandeil, M Nabil Kamel, ... PLoS pathogens 17 (3), e1009413, 2021 | 24 | 2021 |
Ranawaka A.P.M Perera - DrFRCPath(Virology), PDipID(Infectious Diseases), PDipMDPath, Ph.D(Viral Immunology), BDS(Hons)在 va.gov 的电子邮件经过验证
